Non-Oncology Precision Medicine Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Oncology Precision Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Applied Sciences
1.2.3 Precision Diagnostics
1.2.4 Digital Health and Information Technology
1.2.5 Precision Therapeutics
1.3 Market by Application
1.3.1 Global Non-Oncology Precision Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Infectious Diseases
1.3.3 Neurology
1.3.4 Cardiovascular
1.3.5 Lifestyle and Endocrinology
1.3.6 Gastroenterology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Oncology Precision Medicine Market Perspective (2017-2028)
2.2 Non-Oncology Precision Medicine Growth Trends by Region
2.2.1 Non-Oncology Precision Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Non-Oncology Precision Medicine Historic Market Size by Region (2017-2022)
2.2.3 Non-Oncology Precision Medicine Forecasted Market Size by Region (2023-2028)
2.3 Non-Oncology Precision Medicine Market Dynamics
2.3.1 Non-Oncology Precision Medicine Industry Trends
2.3.2 Non-Oncology Precision Medicine Market Drivers
2.3.3 Non-Oncology Precision Medicine Market Challenges
2.3.4 Non-Oncology Precision Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Oncology Precision Medicine Players by Revenue
3.1.1 Global Top Non-Oncology Precision Medicine Players by Revenue (2017-2022)
3.1.2 Global Non-Oncology Precision Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Oncology Precision Medicine Revenue
3.4 Global Non-Oncology Precision Medicine Market Concentration Ratio
3.4.1 Global Non-Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Oncology Precision Medicine Revenue in 2021
3.5 Non-Oncology Precision Medicine Key Players Head office and Area Served
3.6 Key Players Non-Oncology Precision Medicine Product Solution and Service
3.7 Date of Enter into Non-Oncology Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Oncology Precision Medicine Breakdown Data by Type
4.1 Global Non-Oncology Precision Medicine Historic Market Size by Type (2017-2022)
4.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2023-2028)
5 Non-Oncology Precision Medicine Breakdown Data by Application
5.1 Global Non-Oncology Precision Medicine Historic Market Size by Application (2017-2022)
5.2 Global Non-Oncology Precision Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-Oncology Precision Medicine Market Size (2017-2028)
6.2 North America Non-Oncology Precision Medicine Market Size by Type
6.2.1 North America Non-Oncology Precision Medicine Market Size by Type (2017-2022)
6.2.2 North America Non-Oncology Precision Medicine Market Size by Type (2023-2028)
6.2.3 North America Non-Oncology Precision Medicine Market Share by Type (2017-2028)
6.3 North America Non-Oncology Precision Medicine Market Size by Application
6.3.1 North America Non-Oncology Precision Medicine Market Size by Application (2017-2022)
6.3.2 North America Non-Oncology Precision Medicine Market Size by Application (2023-2028)
6.3.3 North America Non-Oncology Precision Medicine Market Share by Application (2017-2028)
6.4 North America Non-Oncology Precision Medicine Market Size by Country
6.4.1 North America Non-Oncology Precision Medicine Market Size by Country (2017-2022)
6.4.2 North America Non-Oncology Precision Medicine Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Non-Oncology Precision Medicine Market Size (2017-2028)
7.2 Europe Non-Oncology Precision Medicine Market Size by Type
7.2.1 Europe Non-Oncology Precision Medicine Market Size by Type (2017-2022)
7.2.2 Europe Non-Oncology Precision Medicine Market Size by Type (2023-2028)
7.2.3 Europe Non-Oncology Precision Medicine Market Share by Type (2017-2028)
7.3 Europe Non-Oncology Precision Medicine Market Size by Application
7.3.1 Europe Non-Oncology Precision Medicine Market Size by Application (2017-2022)
7.3.2 Europe Non-Oncology Precision Medicine Market Size by Application (2023-2028)
7.3.3 Europe Non-Oncology Precision Medicine Market Share by Application (2017-2028)
7.4 Europe Non-Oncology Precision Medicine Market Size by Country
7.4.1 Europe Non-Oncology Precision Medicine Market Size by Country (2017-2022)
7.4.2 Europe Non-Oncology Precision Medicine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Oncology Precision Medicine Market Size (2017-2028)
8.2 Asia-Pacific Non-Oncology Precision Medicine Market Size by Type
8.2.1 Asia-Pacific Non-Oncology Precision Medicine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Non-Oncology Precision Medicine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Non-Oncology Precision Medicine Market Share by Type (2017-2028)
8.3 Asia-Pacific Non-Oncology Precision Medicine Market Size by Application
8.3.1 Asia-Pacific Non-Oncology Precision Medicine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Non-Oncology Precision Medicine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Non-Oncology Precision Medicine Market Share by Application (2017-2028)
8.4 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region
8.4.1 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-Oncology Precision Medicine Market Size (2017-2028)
9.2 Latin America Non-Oncology Precision Medicine Market Size by Type
9.2.1 Latin America Non-Oncology Precision Medicine Market Size by Type (2017-2022)
9.2.2 Latin America Non-Oncology Precision Medicine Market Size by Type (2023-2028)
9.2.3 Latin America Non-Oncology Precision Medicine Market Share by Type (2017-2028)
9.3 Latin America Non-Oncology Precision Medicine Market Size by Application
9.3.1 Latin America Non-Oncology Precision Medicine Market Size by Application (2017-2022)
9.3.2 Latin America Non-Oncology Precision Medicine Market Size by Application (2023-2028)
9.3.3 Latin America Non-Oncology Precision Medicine Market Share by Application (2017-2028)
9.4 Latin America Non-Oncology Precision Medicine Market Size by Country
9.4.1 Latin America Non-Oncology Precision Medicine Market Size by Country (2017-2022)
9.4.2 Latin America Non-Oncology Precision Medicine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Oncology Precision Medicine Market Size (2017-2028)
10.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Type
10.2.1 Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Non-Oncology Precision Medicine Market Share by Type (2017-2028)
10.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Application
10.3.1 Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Non-Oncology Precision Medicine Market Share by Application (2017-2028)
10.4 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country
10.4.1 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Non-Oncology Precision Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Agilent Technologies, Inc.
11.2.1 Agilent Technologies, Inc. Company Details
11.2.2 Agilent Technologies, Inc. Business Overview
11.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Introduction
11.2.4 Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.2.5 Agilent Technologies, Inc. Recent Developments
11.3 Asuragen, Inc.
11.3.1 Asuragen, Inc. Company Details
11.3.2 Asuragen, Inc. Business Overview
11.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Introduction
11.3.4 Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.3.5 Asuragen, Inc. Recent Developments
11.4 Almac Group
11.4.1 Almac Group Company Details
11.4.2 Almac Group Business Overview
11.4.3 Almac Group Non-Oncology Precision Medicine Introduction
11.4.4 Almac Group Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.4.5 Almac Group Recent Developments
11.5 AstraZeneca PLC
11.5.1 AstraZeneca PLC Company Details
11.5.2 AstraZeneca PLC Business Overview
11.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Introduction
11.5.4 AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.5.5 AstraZeneca PLC Recent Developments
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Introduction
11.6.4 Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.6.5 Bristol Myers Squibb Recent Developments
11.7 bioM?rieux SA.
11.7.1 bioM?rieux SA. Company Details
11.7.2 bioM?rieux SA. Business Overview
11.7.3 bioM?rieux SA. Non-Oncology Precision Medicine Introduction
11.7.4 bioM?rieux SA. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.7.5 bioM?rieux SA. Recent Developments
11.8 BGI
11.8.1 BGI Company Details
11.8.2 BGI Business Overview
11.8.3 BGI Non-Oncology Precision Medicine Introduction
11.8.4 BGI Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.8.5 BGI Recent Developments
11.9 Danaher Corp.
11.9.1 Danaher Corp. Company Details
11.9.2 Danaher Corp. Business Overview
11.9.3 Danaher Corp. Non-Oncology Precision Medicine Introduction
11.9.4 Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.9.5 Danaher Corp. Recent Developments
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Non-Oncology Precision Medicine Introduction
11.10.4 Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.10.5 Illumina, Inc. Recent Developments
11.11 Invitae Corporation
11.11.1 Invitae Corporation Company Details
11.11.2 Invitae Corporation Business Overview
11.11.3 Invitae Corporation Non-Oncology Precision Medicine Introduction
11.11.4 Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.11.5 Invitae Corporation Recent Developments
11.12 Opko Health, Inc.
11.12.1 Opko Health, Inc. Company Details
11.12.2 Opko Health, Inc. Business Overview
11.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Introduction
11.12.4 Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.12.5 Opko Health, Inc. Recent Developments
11.13 Teva Pharmaceutical Industries Ltd.
11.13.1 Teva Pharmaceutical Industries Ltd. Company Details
11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Introduction
11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2017-2022)
11.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Non-Oncology Precision Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Applied Sciences
Table 3. Key Players of Precision Diagnostics
Table 4. Key Players of Digital Health and Information Technology
Table 5. Key Players of Precision Therapeutics
Table 6. Global Non-Oncology Precision Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Non-Oncology Precision Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Non-Oncology Precision Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Non-Oncology Precision Medicine Market Share by Region (2017-2022)
Table 10. Global Non-Oncology Precision Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Non-Oncology Precision Medicine Market Share by Region (2023-2028)
Table 12. Non-Oncology Precision Medicine Market Trends
Table 13. Non-Oncology Precision Medicine Market Drivers
Table 14. Non-Oncology Precision Medicine Market Challenges
Table 15. Non-Oncology Precision Medicine Market Restraints
Table 16. Global Non-Oncology Precision Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Non-Oncology Precision Medicine Revenue Share by Players (2017-2022)
Table 18. Global Top Non-Oncology Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Oncology Precision Medicine as of 2021)
Table 19. Ranking of Global Top Non-Oncology Precision Medicine Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Non-Oncology Precision Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Non-Oncology Precision Medicine Product Solution and Service
Table 23. Date of Enter into Non-Oncology Precision Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-Oncology Precision Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2017-2022)
Table 27. Global Non-Oncology Precision Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Non-Oncology Precision Medicine Revenue Market Share by Type (2023-2028)
Table 29. Global Non-Oncology Precision Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Non-Oncology Precision Medicine Revenue Share by Application (2017-2022)
Table 31. Global Non-Oncology Precision Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Non-Oncology Precision Medicine Revenue Share by Application (2023-2028)
Table 33. North America Non-Oncology Precision Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Non-Oncology Precision Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Non-Oncology Precision Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Non-Oncology Precision Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Non-Oncology Precision Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Non-Oncology Precision Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Non-Oncology Precision Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Non-Oncology Precision Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Non-Oncology Precision Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Non-Oncology Precision Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Non-Oncology Precision Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Non-Oncology Precision Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Non-Oncology Precision Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Non-Oncology Precision Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Non-Oncology Precision Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Non-Oncology Precision Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Non-Oncology Precision Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Non-Oncology Precision Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Non-Oncology Precision Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Non-Oncology Precision Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Non-Oncology Precision Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Non-Oncology Precision Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Non-Oncology Precision Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Non-Oncology Precision Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Non-Oncology Precision Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Non-Oncology Precision Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Non-Oncology Precision Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Non-Oncology Precision Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Non-Oncology Precision Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Non-Oncology Precision Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Non-Oncology Precision Medicine Product
Table 66. Abbott Laboratories Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 67. Abbott Laboratories Recent Developments
Table 68. Agilent Technologies, Inc. Company Details
Table 69. Agilent Technologies, Inc. Business Overview
Table 70. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product
Table 71. Agilent Technologies, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 72. Agilent Technologies, Inc. Recent Developments
Table 73. Asuragen, Inc. Company Details
Table 74. Asuragen, Inc. Business Overview
Table 75. Asuragen, Inc. Non-Oncology Precision Medicine Product
Table 76. Asuragen, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 77. Asuragen, Inc. Recent Developments
Table 78. Almac Group Company Details
Table 79. Almac Group Business Overview
Table 80. Almac Group Non-Oncology Precision Medicine Product
Table 81. Almac Group Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 82. Almac Group Recent Developments
Table 83. AstraZeneca PLC Company Details
Table 84. AstraZeneca PLC Business Overview
Table 85. AstraZeneca PLC Non-Oncology Precision Medicine Product
Table 86. AstraZeneca PLC Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 87. AstraZeneca PLC Recent Developments
Table 88. Bristol Myers Squibb Company Details
Table 89. Bristol Myers Squibb Business Overview
Table 90. Bristol Myers Squibb Non-Oncology Precision Medicine Product
Table 91. Bristol Myers Squibb Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 92. Bristol Myers Squibb Recent Developments
Table 93. bioM?rieux SA. Company Details
Table 94. bioM?rieux SA. Business Overview
Table 95. bioM?rieux SA. Non-Oncology Precision Medicine Product
Table 96. bioM?rieux SA. Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 97. bioM?rieux SA. Recent Developments
Table 98. BGI Company Details
Table 99. BGI Business Overview
Table 100. BGI Non-Oncology Precision Medicine Product
Table 101. BGI Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 102. BGI Recent Developments
Table 103. Danaher Corp. Company Details
Table 104. Danaher Corp. Business Overview
Table 105. Danaher Corp. Non-Oncology Precision Medicine Product
Table 106. Danaher Corp. Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 107. Danaher Corp. Recent Developments
Table 108. Illumina, Inc. Company Details
Table 109. Illumina, Inc. Business Overview
Table 110. Illumina, Inc. Non-Oncology Precision Medicine Product
Table 111. Illumina, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 112. Illumina, Inc. Recent Developments
Table 113. Invitae Corporation Company Details
Table 114. Invitae Corporation Business Overview
Table 115. Invitae Corporation Non-Oncology Precision Medicine Product
Table 116. Invitae Corporation Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 117. Invitae Corporation Recent Developments
Table 118. Opko Health, Inc. Company Details
Table 119. Opko Health, Inc. Business Overview
Table 120. Opko Health, Inc. Non-Oncology Precision Medicine Product
Table 121. Opko Health, Inc. Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 122. Opko Health, Inc. Recent Developments
Table 123. Teva Pharmaceutical Industries Ltd. Company Details
Table 124. Teva Pharmaceutical Industries Ltd. Business Overview
Table 125. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product
Table 126. Teva Pharmaceutical Industries Ltd. Revenue in Non-Oncology Precision Medicine Business (2017-2022) & (US$ Million)
Table 127. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Oncology Precision Medicine Market Share by Type: 2021 VS 2028
Figure 2. Applied Sciences Features
Figure 3. Precision Diagnostics Features
Figure 4. Digital Health and Information Technology Features
Figure 5. Precision Therapeutics Features
Figure 6. Global Non-Oncology Precision Medicine Market Share by Application: 2021 VS 2028
Figure 7. Infectious Diseases Case Studies
Figure 8. Neurology Case Studies
Figure 9. Cardiovascular Case Studies
Figure 10. Lifestyle and Endocrinology Case Studies
Figure 11. Gastroenterology Case Studies
Figure 12. Others Case Studies
Figure 13. Non-Oncology Precision Medicine Report Years Considered
Figure 14. Global Non-Oncology Precision Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Non-Oncology Precision Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Non-Oncology Precision Medicine Market Share by Region: 2021 VS 2028
Figure 17. Global Non-Oncology Precision Medicine Market Share by Players in 2021
Figure 18. Global Top Non-Oncology Precision Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Oncology Precision Medicine as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Non-Oncology Precision Medicine Revenue in 2021
Figure 20. North America Non-Oncology Precision Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Non-Oncology Precision Medicine Market Size Market Share by Type (2017-2028)
Figure 22. North America Non-Oncology Precision Medicine Market Size Market Share by Application (2017-2028)
Figure 23. North America Non-Oncology Precision Medicine Market Size Share by Country (2017-2028)
Figure 24. United States Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Non-Oncology Precision Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Non-Oncology Precision Medicine Market Size Market Share by Type (2017-2028)
Figure 28. Europe Non-Oncology Precision Medicine Market Size Market Share by Application (2017-2028)
Figure 29. Europe Non-Oncology Precision Medicine Market Size Share by Country (2017-2028)
Figure 30. Germany Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Non-Oncology Precision Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Non-Oncology Precision Medicine Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Non-Oncology Precision Medicine Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Non-Oncology Precision Medicine Market Size Share by Region (2017-2028)
Figure 40. China Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Non-Oncology Precision Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Non-Oncology Precision Medicine Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Non-Oncology Precision Medicine Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Non-Oncology Precision Medicine Market Size Share by Country (2017-2028)
Figure 50. Mexico Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Non-Oncology Precision Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Non-Oncology Precision Medicine Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Non-Oncology Precision Medicine Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Non-Oncology Precision Medicine Market Size Share by Country (2017-2028)
Figure 56. Turkey Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Non-Oncology Precision Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 60. Agilent Technologies, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 61. Asuragen, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 62. Almac Group Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 63. AstraZeneca PLC Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 64. Bristol Myers Squibb Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 65. bioM?rieux SA. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 66. BGI Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 67. Danaher Corp. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 68. Illumina, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 69. Invitae Corporation Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 70. Opko Health, Inc. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 71. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Non-Oncology Precision Medicine Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Industry Market Size
